Abstract
Thyroid hormones (THs) are essential for normal development of the mammalian central nervous system through regulation of TH-responsive genes. EphA5, an important TH-responsive gene encoding the tyrosine kinase receptor EphA5, regulates synaptogenesis initiation and synaptic remodeling during brain development. Abnormal EphA5 expression is involved in the development of congenital hypothyroidism (CH). To show the regulatory mechanism of EphA5 expression in CH rats, we analyzed the correlation between methylation of the EphA5 promoter and its expression in the hypothyroid hippocampus and hippocampal neurons. Demethylation treatment using 5′-azadeoxycytidine upregulated EphA5 expression and rescued the effects of hypermethylation, suggesting a novel regulatory mechanism of EphA5 expression in CH rats. Our results suggest a potentially new approach for the development of drugs to restore neurocognitive impairments associated with CH.
Similar content being viewed by others
References
Akaneya Y, Sohya K, Kitamura A, Kimura F, Washburn C, Zhou R, Ninan I, Tsumoto T, Ziff EB (2010) Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. PLoS One 5(8):e12486
Andres AC, Reid HH, Zürcher G, Blaschke RJ, Albrecht D, Ziemiecki A (1994) Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis. Oncogene 9(5):1461–1467
Baylin SB, Herman JG (2010) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16(4):168–174
Cooper MA, Crockett DP, Nowakowski RS, Gale NW, Zhou R (2009) Distribution of EphA5 receptor protein in the developing and adult mouse nervous system. J Comp Neurol 514(4):310–328
Cowan CW, Shao YR, Sahin M, Shamah SM, Lin MZ, Greer PL, Gao S, Griffith EC, Brugge JS, Greenberg ME (2005) Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron 46(2):205–217
Dottori M, Down M, Huttmann A, Fitzpatrick DR, Boyd AW (2010) Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. Blood 94(7):2477–2486
Egger G, Liang G, Aparicio A, Jones PA (2008) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429(6990):457–463
Ehrich M, Turner J, Gibbs P, Lipton L, Giovanneti M, Cantor C, van den Boom D (2010) Cytosine methylation profiling of cancer cell lines. Proc Natl Acad Sci U S A 105(12):4844–4849
Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM (2010) Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer. Hum Pathol 41(1):48–58
Hermanns P, Shepherd S, Mansor M, Schulga J, Jones J, Donaldson M, Pohlenz J (2014) A new mutation in the promoter region of the PAX8 gene causes true congenital hypothyroidism with thyroid hypoplasia in a girl with Down’s syndrome. Thyroid 24(6):939–944
Huot J (2004) Ephrin signaling in axon guidance. Prog Neuro-Psychopharmacol Biol Psychiatry 28(5):813–818
Kamitori K, Tanaka M, Okuno-Hirasawa T, Kohsaka S (2005) Receptor related to tyrosine kinase RYK regulates cell migration during cortical development. Biochem Biophys Res Commun 330(2):446–453
Kinch MS, Moore MB, Harpole DH Jr (2003) Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res 9(2):613–618
Liu W, Ahmad SA, Jung YD, Reinmuth N, Fan F, Bucana CD, Ellis LM (2002) Coexpression of ephrin-Bs and their receptors in colon carcinoma. Cancer 94(4):934–939
Macchia PE (2000) Recent advances in understanding the molecular basis of primary congenital hypothyroidism. Mol Med Today 6(1):36–42
Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205):766–770
Merlos-Suarez A, Battle E (2008) Eph-ephrin signaling in adult tissues and cancer. Curr Opin Cell Biol 20(2):194–200
Nakamoto M (2000) Eph receptors and ephrins. Int J Biochem Cell Biol 32(1):7–12
Nestor MW, Mok LP, Tulapurkar ME, Thompson SM (2007) Plasticity of neuron-glial interactions mediated by astrocytic EphARs. J Neurosci 27(47):12817–12828
Olivieri A, Fazzini C, Medda E, Collaborators (2015) Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Horm Res Paediatr 83(2):86–93
Oppenheimer JH, Schwartz HL (1997) Molecular basis of thyroid hormone-dependent brain development. Endocr Rev 18(4):462–475
Pasquale EB (2005) Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6(6):462–475
Petkova TD, Seigel GM, Otteson DC (2010) A role for DNA methylation in regulation of EphA5 receptor expression in the mouse retina. Vis Res 51(2):260–268
Rovet JF (2002) Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Child Neuropsychol 8(3):150–162
Sasaki H, Matsui Y (2008) Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat Rev Genet 9(2):129–140
Schwartz HL, Ross ME, Oppenheimer JH (1997) Lack of effects of thyroid hormone on late fetal rat brain development. Endocrinology 138(8):3119–3124
Sui L, Li BM (2010) Effects of perinatal hypothyroidism on regulation of reelin and brain-derived neurotrophic factor gene expression in rat hippocampus: role of DNA methylation and histone acetylation. Steroids 75(12):988–997
Targovnik HM, Esperante SA, Rivolta CM (2010) Genetics and phenomics of hypothyroidism and goiter due to thyroglobulin mutations. Mol Cell Endocrinol 322(1-2):44–55
Targovnik HM, Citterio CE, Rivolta CM (2011) Thyroglobulin gene mutations in congenital hypothyroidism. Horm Res Paediatr 75(5):311–321
Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS (1999) Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate 41(4):275–280
Wang J, Kataoka H, Suzuki M, Sato N, Nakamura R, Tao H, Maruyama K, Isogaki J, Kanaoka S, Ihara M, Tanaka M, Kanamori M, Nakamura T, Shinmura K, Sugimura H (2010) Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene 24(36):5637–5647
Wu YJ, Xu MY, Wang L, Sun BL, Gu GX (2013) Analysis of EphA5 receptor in the developing rat brain: an in vivo study in congenital hypothyroidism model. Eur J Pediatr 172(8):1077–1083
Yue Y, Chen ZY, Gale NW, Blair-Flynn J, Hu TJ, Yue X, Cooper M, Crockett DP, Yancopoulos GD, Tessarollo L, Zhou R (2002) Mistargeting hippocampal axons by expression of a truncated Eph receptor. Proc Natl Acad Sci U S A 99(16):10777–10782
Zhou R, Copeland TD, Kromer LF, Schulz NT (1994) Isolation and characterization of Bsk, a growth factor receptor-like tyrosine kinase associated with the limbic system. J Neurosci Res 37(1):129–143
Acknowledgments
This study was supported by the Youth Fund of the National Natural Science Foundation of China (81201975), the Youth Fund of the Natural Science Foundation of Jiangsu Province (BK2012224), and the Six Major Human Resources Project of Jiangsu Province (2014-WSW-031).
Conflict of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Youjia Wu and Honghua Song contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wu, Y., Song, H., Sun, B. et al. DNA Methylation of the EphA5 Promoter Is Associated with Rat Congenital Hypothyroidism. J Mol Neurosci 57, 203–210 (2015). https://doi.org/10.1007/s12031-015-0603-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-015-0603-9